Omega-3 study on ES-CLL, MGUS and SMM patients

A blog reader (thanks!) sent me the link (see below) to this Phase II study listed on the Clinical Trials website. The main purpose of the study is to determine if the Omega 3 supplementation will help prevent or delay progression of the disease to a stage that requires treatment. Well, that sounds good to me, especially since my regular regimen includes 4 grams of fish oil/day, which is slightly more than what these patients take in the first month before building to higher doses (the highest dose will be 11 grams and 250 mg/day).

The study is still recruiting, by the way. For more information, see: http://tinyurl.com/n9r49u